论文部分内容阅读
1992年4月14～15日在罗马召开了欧洲艾滋病疫苗(EVA)学术会议。会议主题是有关猿猴免疫缺陷症病毒(SIV)-弥猴模型用于制备人类免疫缺陷症病毒(HIV)疫苗的相关性、对生产灭活疫苗方法的评估以及研制逆转录病毒减毒疫苗的可能性;会议还讨论了人体艾滋病中可能存在的移植物抗宿主病(GVHD)成分;最近研究还揭示,流感疫苗中出现的“抗原性原罪(Originel antigenic、Sin)”现象也可能见于艾滋病;会议认为,用于HIV-1疫苗的动物模型研究结果是令人鼓舞的。现将会议内容报道如下。
European Conference on AIDS Vaccine (EVA) was held in Rome from April 14 to April 15, 1992. The topics of the conference were on the relevance of simian immunodeficiency virus (SIV) -colly monkey models for the preparation of human immunodeficiency virus (HIV) vaccines, assessment of methods for producing inactivated vaccines and possible development of retroviral attenuated vaccines The meeting also discussed the possible presence of graft versus host disease (GVHD) in human AIDS. Recent studies also revealed that the “Originel antigenic (Sin)” phenomenon in influenza vaccines may also be found in AIDS; the meeting The results of the animal model studies for the HIV-1 vaccine are considered encouraging. The meeting is now reported as follows.